Ballreich J - Search Results

1

Attributes common to programs that successfully treat high-need, high-cost individuals.

Anderson GF, Ballreich J, Bleich S, Boyd C, DuGoff E, Leff B, Salzburg C, Wolff J. Anderson GF, et al. Among authors: ballreich j. Am J Manag Care. 2015 Nov 1;21(11):e597-600. Am J Manag Care. 2015. PMID: 26735292 Free article.

2

Bridging the Silos of Service Delivery for High-Need, High-Cost Individuals.

Sherry M, Wolff JL, Ballreich J, DuGoff E, Davis K, Anderson G. Sherry M, et al. Among authors: ballreich j. Popul Health Manag. 2016 Dec;19(6):421-428. doi: 10.1089/pop.2015.0147. Epub 2016 Mar 23. Popul Health Manag. 2016. PMID: 27006987 Free PMC article.

3

Reducing Branded Prescription Drug Prices: A Review of Policy Options.

Alexander GC, Ballreich J, Socal MP, Karmarkar T, Trujillo A, Greene J, Sharfstein J, Anderson G. Alexander GC, et al. Among authors: ballreich j. Pharmacotherapy. 2017 Nov;37(11):1469-1478. doi: 10.1002/phar.2013. Epub 2017 Oct 17. Pharmacotherapy. 2017. PMID: 28805961 Review.

4

Branded prescription drug spending: a framework to evaluate policy options.

Ballreich J, Alexander GC, Socal M, Karmarkar T, Anderson G. Ballreich J, et al. J Pharm Policy Pract. 2017 Oct 2;10:31. doi: 10.1186/s40545-017-0115-9. eCollection 2017. J Pharm Policy Pract. 2017. PMID: 29026611 Free PMC article.

5

Paying for Drugs After the Medicare Part D Beneficiary Reaches the Catastrophic Limit: Lessons on Cost Sharing from Other US Policy Partnerships Between Government and Commercial Industry.

Padula WV, Ballreich J, Anderson GF. Padula WV, et al. Among authors: ballreich j. Appl Health Econ Health Policy. 2018 Dec;16(6):753-763. doi: 10.1007/s40258-018-0417-3. Appl Health Econ Health Policy. 2018. PMID: 30058011 Free PMC article.

6

Allocation of National Institutes of Health Funding by Disease Category in 2008 and 2019.

Ballreich JM, Gross CP, Powe NR, Anderson GF. Ballreich JM, et al. JAMA Netw Open. 2021 Jan 4;4(1):e2034890. doi: 10.1001/jamanetworkopen.2020.34890. JAMA Netw Open. 2021. PMID: 33502486 Free PMC article.

7

The Association Between Drug Approvals and Burden of Disease From 1990 to 2017.

George T, Ballreich J, Trujillo A, Anderson G. George T, et al. Among authors: ballreich j. J Gen Intern Med. 2021 Nov;36(11):3615-3617. doi: 10.1007/s11606-020-06525-3. Epub 2021 Feb 2. J Gen Intern Med. 2021. PMID: 33528780 Free PMC article. No abstract available.

8

Coverage of genetic therapies for spinal muscular atrophy across fee-for-service Medicaid programs.

Ballreich J, Ezebilo I, Khalifa BA, Choe J, Anderson G. Ballreich J, et al. J Manag Care Spec Pharm. 2022 Jan;28(1):39-47. doi: 10.18553/jmcp.2022.28.1.39. J Manag Care Spec Pharm. 2022. PMID: 34949120 Free PMC article.

9

Medicare Spending on Drugs With Accelerated Approval.

Ballreich J, Socal M, Bennett CL, Schoen MW, Trujillo A, Xuan A, Anderson G. Ballreich J, et al. Ann Intern Med. 2022 Jul;175(7):938-944. doi: 10.7326/M21-4442. Epub 2022 May 24. Ann Intern Med. 2022. PMID: 35605235

10

Trajectories of prices in generic drug markets: what can we infer from looking at trajectories rather than average prices?

Trujillo AJ, Gutierrez JC, Garcia Morales EE, Socal M, Ballreich J, Anderson G. Trujillo AJ, et al. Among authors: ballreich j. Health Econ Rev. 2022 Jul 11;12(1):37. doi: 10.1186/s13561-022-00384-w. Health Econ Rev. 2022. PMID: 35819735 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

49 results

Search Page